CLINICAL_TRIALS
trial_result
· 2026-01-28
Clinical Trial Update: Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures. [Phase 1, Phase 2]
Summary
A Phase 1/2 proof-of-concept trial evaluating NVDX3 for distal radius fractures has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novadip Biosciences | Conditions: Distal Radius Fractures | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-01-28